Abbott Launches Feasibility Trial Of Tricuspid Version Of MitraClip

 
• By Reed Miller

The TRILUMINATE trial will evaluate safety and effectiveness of its Tricuspid Valve Repair System for treating symptomatic moderate-to-severe tricuspid regurgitation. The device is similar to Abbott's successful MitraClip catheter-based device for treating mitral regurgitation.

More from Clinical Trials

More from R&D